as 03-07-2025 3:39pm EST
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.
Founded: | 2005 | Country: | United States |
Employees: | N/A | City: | ATLANTA |
Market Cap: | 3.3B | IPO Year: | N/A |
Target Price: | $19.25 | AVG Volume (30 days): | 2.2M |
Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.18 | EPS Growth: | N/A |
52 Week Low/High: | $9.11 - $18.81 | Next Earning Date: | 04-29-2025 |
Revenue: | $860,800,000 | Revenue Growth: | 7.48% |
Revenue Growth (this year): | 5.54% | Revenue Growth (next year): | 7.44% |
MIR Breaking Stock News: Dive into MIR Ticker-Specific Updates for Smart Investing
Business Wire
11 days ago
IPO-Edge.com
18 days ago
Business Wire
23 days ago
Simply Wall St.
24 days ago
Business Wire
25 days ago
Zacks
a month ago
Business Wire
2 months ago
Simply Wall St.
2 months ago
The information presented on this page, "MIR Mirion Technologies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.